ENOS 4a/b polymorphism and its interaction with eNOS G894T variants in type 2 diabetes mellitus: Modifying the risk of diabetic nephropathy

Disease Markers

Volumn 34, Issue 6, 2013, Pages 437-443

  Rahimi, Zohreh ^a,b   Rahimi, Ziba ^a   Shahvaisi Zadeh, Frahad ^a   Sadeghei, Shieda ^c   Vessal, Mahmood ^c   Yavari, Niloofar ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

diabetic nephropathy; eNOS variants; T2DM; Western Iran

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 84878834056     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/512107     Document Type: Article

References (19)

1. A.L. Mooyaart, E.J.J. Valk , L.A. van Es, J.A. Bruijn, E. de Heer, B.I. Freedman, O.M. Dekkers, H.J. Baelde. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologica 2011; 54: 544-553.
2. M.H. Bellini, M.N. Figueira, M.F. Piccoli, J.T.Marumo, M.S. Cendoroglo, M.C. Neto, M.A. Dalboni, M.C. Batista, M.A. Goes, N. Schor. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology 2007; 12: 289-293.
3. T.S. Ahluwalia, M. Ahuja, T.S. Rai, H.S. Kohli, K. Sud , A. Bhansali, M. Khullar. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol Cell Biochem 2008; 314: 9-17.
4. Y. He, Z. Fan, J. Zhang, Q. Zhang, M. Zheng, Y. Li, D. Zhang, S. Gu, H. Yang. Polymorphisms of eNOS gene are associated with diabetic nephropathy: a meta-analysis. Mutagenesis 2011; 26: 339-349.
5. F. Thameem, S. Puppala, N.H. Arar, M.P. Stern, J. Blangero, R. Duggirala, H.E. Abboud. Endothelial nitric oxide synthase (eNOS) gene polymorphisms and their association with type 2 diabetes-related traits in Mexican Americans. Diab Vasc Dis Res 2008; 5; 109-113.
6. E. Zintzaras, A.A. Papathanasiou, I. Stefanidis. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: A HuGE review and meta-analysis. Genet Med 2009; 11: 695-706.
7. I. Ezzidi, N. Mtiraoui, M.B. Hadj Mohamed, T. Mahjoub, M. Kacem, W.Y. Almawi. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and ?786TNC gene variants with diabetic nephropathy. J Diabetes & Its Complications 2008; 22: 331-338.
8. M. Mehrab-Mohseni, O. Tabatabaei-Malazy, S.H. Hasani-Ranjbar, P. Amiri, A. Kouroshnia, J. Tavakkoly Bazzaz, M. Farahani-Shrhabi, B. Larijani, M.M. Amoli. Endothelial nitric oxide synthase VNTR (intron 4 a/b) polymorphism association with type 2 diabetes and its chronic complications. Diabetes Res and Clin Practice 2011; 91: 348-352.
9. S. Neugebauer, T. Baba, T. Watanabe. Association of nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephrophathy in type 2 diabetes. Diabetes 2000; 49: 500-503.
10. K.G. Santos, D. Crispim, L.H. Canani, P.T. Ferrugem, J.L. Gross, I. Roisenberg. Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes. Diabetes Res and Clin Practice 2011; 91: 353-362.
11. Y. Jafari, Z. Rahimi, A. Vaisi-Raygani, M. Rezaei. Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients. Mol Cell Biochem 2011; 353: 23-34.
12. Z. Rahimi, A. Vaisi-Raygani, Z. Rahimi, A. Parsian. The Concomitant Presence of eNOS 894T and ACE D Alleles Are Associated with Diabetic Nephropathy in Kurdish Population from Western Iran. Nephrology 2012; 17: 175-181.
13. WHO Study Group Report of aWHO consultation (1999) Part 1. Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva.
14. J.M. Old, D.R. Higgs. Gene analysis, in:Weatherall DJ (Eds), Methods in Hemotology. Vol:6. The thalassemias. Livingstone, 1983, pp.74-101.
15. Y Miyamoto, Y. Saito, N. Kajiyama, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32: 3-8.
16. S. Rodriguez, T.R. Gaunt, I.N.M. Day. Hardy-Weinberg equilibrium testing of biological ascertainment for mendelian randomization studies. Am J Epidemiol 2009; 169: 505-514.
17. A.E. Raptis, G. Vibert. Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2001; 109: S424-437.
18. Y. Shin Shin, S.H. Baek, K.Y. Chang, et al. Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract 2004; 65: 257-265.
19. A. Zanchi, D.K. Moczulski, L.S. Hanna, et al. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney International 2000; 57: 405-413.